<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03936569</url>
  </required_header>
  <id_info>
    <org_study_id>2018122</org_study_id>
    <nct_id>NCT03936569</nct_id>
  </id_info>
  <brief_title>A Clinical Study to Assess the Plaque and Gingivitis Effects of a Stannous Fluoride Dentifrice</brief_title>
  <official_title>A 3-Month Clinical Study to Assess the Plaque and Gingivitis Effects of a Stannous Fluoride Dentifrice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Procter and Gamble</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Procter and Gamble</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this clinical study is to assess the effects of a 0.454% stannous fluoride
      dentifrice on gingivitis and plaque after 3 months when compared to a negative control.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 2018</start_date>
  <completion_date type="Actual">January 25, 2019</completion_date>
  <primary_completion_date type="Actual">January 25, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Löe-Silness Gingivitis Evaluation</measure>
    <time_frame>Baseline</time_frame>
    <description>Löe-Silness Gingivitis Evaluation is a validated assessment of gingival health looking at inflammation and bleeding based on a 4 point range 0 (normal gingiva) to 3 (severe inflammation).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Löe-Silness Gingivitis Evaluation</measure>
    <time_frame>1 Month</time_frame>
    <description>Löe-Silness Gingivitis Evaluation is a validated assessment of gingival health looking at inflammation and bleeding based on a 4 point range 0 (normal gingiva) to 3 (severe inflammation).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Löe-Silness Gingivitis Evaluation</measure>
    <time_frame>3 Months</time_frame>
    <description>Löe-Silness Gingivitis Evaluation is a validated assessment of gingival health looking at inflammation and bleeding based on a 4 point range 0 (normal gingiva) to 3 (severe inflammation).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Turesky Modified Quigley-Hein Index</measure>
    <time_frame>Baseline</time_frame>
    <description>The Turesky Modified Quigley-Hein Index is a validated assessment of dental plaque based on a scale of 0 (no plaque/debris) to 5 (plaque covering two-thirds or more of the side of the crown or tooth).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Turesky Modified Quigley-Hein Index</measure>
    <time_frame>1 Month</time_frame>
    <description>The Turesky Modified Quigley-Hein Index is a validated assessment of dental plaque based on a scale of 0 (no plaque/debris) to 5 (plaque covering two-thirds or more of the side of the crown or tooth).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Turesky Modified Quigley-Hein Index</measure>
    <time_frame>3 Months</time_frame>
    <description>The Turesky Modified Quigley-Hein Index is a validated assessment of dental plaque based on a scale of 0 (no plaque/debris) to 5 (plaque covering two-thirds or more of the side of the crown or tooth).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Gingivitis</condition>
  <arm_group>
    <arm_group_label>Marketed Stannous Fluoride Toothpaste</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brush twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Marketed Cavity Protection Toothpaste</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Brush twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Marketed Toothpaste</intervention_name>
    <description>Marketed stannous fluoride (0.454%) toothpaste</description>
    <arm_group_label>Marketed Stannous Fluoride Toothpaste</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Marketed Cavity Protection Toothpaste</intervention_name>
    <description>Marketed sodium monofluorophosphate (0.76 %) toothpaste</description>
    <arm_group_label>Marketed Cavity Protection Toothpaste</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be at least 18 years of age;

          -  Provide written informed consent prior to participation and be given a signed copy of
             the informed consent form;

          -  Be in general good health as determined by the Investigator based on a review of the
             health history/update for participation in the trial;

          -  Have at least 16 gradable teeth;

          -  Agree to return for scheduled visits and follow the study procedures;

          -  Agree to refrain from use of any non-study oral hygiene products for the duration of
             the study;

          -  Agree to delay any elective dentistry, including dental prophylaxis, until the
             completion of the study.

        Exclusion Criteria:

          -  Having taken antibiotic, anti-inflammatory, or anti-coagulant medications within 4
             weeks of the Baseline Visit;

          -  Have any oral conditions that could interfere with study compliance and/or examination
             procedures, such as widespread caries, soft or hard tissue tumor of the oral cavity,
             or advanced periodontal disease;

          -  Removable oral appliances;

          -  Fixed facial or lingual orthodontic appliances;

          -  Self-reported pregnancy or lactation;

          -  Any diseases or condition that might interfere with the safe participation in the
             study; and

          -  Inability to undergo study procedures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Silverstone Research Group</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89146</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>May 1, 2019</study_first_submitted>
  <study_first_submitted_qc>May 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2019</study_first_posted>
  <last_update_submitted>December 2, 2019</last_update_submitted>
  <last_update_submitted_qc>December 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

